The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients

This publication has 29 references indexed in Scilit:

• CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment
  Frontiers in Genetics, 2012
• Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
  Journal of Ovarian Research, 2011
• Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
  Genes & Development, 2011
• Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas
  Genes & Cancer, 2011
• A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer
  BMC Systems Biology, 2011
• A map of human genome variation from population-scale sequencing
  Nature, 2010
• The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells
  Clinical Cancer Research, 2008
• Geographical Variations in TP53 Mutational Spectrum in Ovarian Carcinomas
  Annals of Human Genetics, 2006
• A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
  Journal of the American Statistical Association, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001